Skip to content

Senegal Gets Boost for Vaccine Production

The Coalition for Epidemic Preparedness (Cepi) will invest up to $50m over 10 years to help Senegal’s Institut Pasteur expand Africa’s ability to produce vaccines at scale. The deal — which will also reserve capacity to produce vaccines specifically for Global South countries during future outbreaks of disease — will help Africa take charge of its own health security, said Cepi CEO Richard Hatchett. The funds, which will initially include up to $15m over three years, will support development of the institute’s manufacturing facilities for routine and outbreak vaccinations. Cepi, a global initiative headquartered in Norway, is creating a network of vaccine manufacturers in developing countries to help boost capacity and reserves for future outbreaks and pandemics.